This population-level study was conducted to define the health-related quality of life (HRQL) of individuals living with and beyond colorectal cancer (CRC) and to identify factors associated with poor health outcomes.
INTRODUCTION
The population living with or beyond a diagnosis of colorectal cancer (CRC) is increasing and is projected to increase from 1.2 million in 2012 to 1.5 million in 2022 in the United States 1 and from 240,000 in 2010 to 630,000 by 2040 in the United Kingdom. 2 Survivors of cancer report significant unmet needs. 3, 4 Targeted aftercare may improve care quality through focused delivery of resources. However, this requires evidence of the prevalence, extent, and impact of resultant morbidities.
Patient-reported outcome measures (PROMs) may be used to drive changes in the organization and delivery of health care. 5 Provider organizations are increasingly collecting cancer PROMs, but these data are not yet available on a national basis. This is in contrast to patient-reported experience measures, such as the English National Cancer Patient Experience Survey, 6 which collects information on patients' self-reported health care experience rather than self-reported outcomes (as measured by PROMs). Complementary information on survival is collected by the National Cancer Registration Service (NCRS). 7 The addition of patient-reported outcomes to robust survival and experience data will provide the potential for a comprehensive quality account of cancer services.
A growing body of evidence highlights the unwanted consequences of CRC treatment, including bowel, urinary, and sexual problems. [8] [9] [10] Most of this information has been derived from highly selected groups, including clinical trials or small-scale retrospective hospital series, with a lack of whole population-based data. Although studies increasingly use cancer registries to identify more representative samples, 11 to our knowledge, none have previously reported at a national level in the United Kingdom.
Our primary objective was to define, at a population level, the health-related quality of life (HRQL) of individuals living with and beyond CRC diagnosed 12 to 36 months earlier in England. The secondary objective was to identify factors associated with poor reported health outcomes that could be used to support enhanced aftercare.
PATIENTS AND METHODS

Study Design and Survey Process
The study design followed that of a recent pilot study. 12 Individuals older than age 16 years surviving 12 to 36 months after a diagnosis of CRC (International Statistical Classification of Disease and Related Health Problems, Tenth Revision 13 codes C18 to C20) in 2010 or 2011 and treated in the National Health Service in England were identified via the NCRS. We estimate that more than 98% of all eligible individuals were identified. 14 Results from the pilot study demonstrated that HRQL and physical problems remained relatively constant with time (between 12 and 60 months after diagnosis) 12 ; hence, only patients who were 12 to 36 months after diagnosis were included. Individuals were sent a questionnaire accompanied by a letter from their treating cancer center. Patients consented by returning completed questionnaires and declined by not returning the questionnaires or returning blank questionnaires. Two reminders were sent to nonresponders. A dedicated freephone helpline was provided to resolve any queries.
Permission to approach patients without informed consent was given by the National Information Governance Board 
Questionnaire Design
The specific components of the questionnaire and the cognitive testing performed have been described elsewhere. 12 Briefly, the content (Data Supplement) included questions related to treatment, disease status, long-term conditions (LTCs), generic HRQL (EuroQol-5D [EQ-5D]), 15 CRC-specific outcomes (Functional Assessment of Cancer Therapy [FACT]), 16 social problems (Social Difficulties Inventory), 17 and experience of care. 6 Respondents could provide free text comments (to be reported elsewhere).
Data Handling
Age, sex, tumor site, and Dukes' stage of disease at diagnosis were obtained from cancer registration data. Age was categorized as less than 55, 55 to 64, 65 to 74, 75 to 84, and Ն 85 years. Deprivation category was based on the Index of Multiple Deprivation, 18 derived using the postcode of residence. A number of variables were derived from the questionnaire data. Selfreported race was grouped into white and nonwhite. Participants were asked if they had any other LTCs at the time of questionnaire completion and to identify these from a given list (Data Supplement). This variable was categorized as none, one, two, or Ն three other LTCs. Information on self-reported disease status (remission, treated but still present, no treatment, recurrence, or not certain), treatments (surgery, radiotherapy, and chemotherapy), and stoma status (present, reversed, or never formed) was taken from the questionnaire. Records with missing data were retained and categorized as not reported.
The five-level version of the EQ-5D 15 records problems on five domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). These data may be summarized as a single index score using a standard crosswalk algorithm
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; scores range from Ϫ0.5 to 1, where 1 is the maximum score for an individual reporting no problems in any domain. The distribution of the EQ-5D scores is left skewed (median, 0.84; interquartile range, 0.71 to 1.0), with a large peak at the right tail (those scoring 1), and this makes it difficult to model. A simple approach was used to count the number of domains with a problem reported, regardless of the severity of the problem. Records with no response on one or more domains were excluded from this analysis (4.6%).
Cancer-specific questions from FACT were examined separately (FACT total score could not be calculated because not all questions were included as a result of previous cognitive testing). 4 Outcomes relating to bowel control, diarrhea, and urinary function are presented here. Analysis of questions relating to bowel function was limited to patients without a stoma, because it was individuals age Ͼ 16 years) measured HRQL using the EQ-5D. The CRC PROMs and HSE data sets were age and sex matched, creating a comparable sample of 4,615 individuals with EQ-5D responses on all five domains (this lower number reflects the different age profiles of the two surveys). 
Statistical Analysis
Descriptive statistics were used to compare respondent characteristics, EQ-5D domain responses, and cancer-specific outcomes across CRC sites (colon, rectosigmoid junction, and rectum).
2 tests were used to compare categorical variables. Multivariable logistic regression was performed using a binary outcome variable-perfect health (no problems on EQ-5D) or less than perfect health (Ն one problem). Variables predictive of less than perfect health were chosen initially based on their a priori clinical and public health importance, and final model selection was informed by univariable results and statistical validity (eg, collinearity among variables). Analyses were performed using Stata version 13 (Stata, College Station, TX).
RESULTS
Response Rates
NCRS identified 35,213 individuals diagnosed with CRC 12 to 36 months previously; 746 of individuals (2.1%) died before or during the survey process, giving a final eligible sample of 34,467 (Fig 1) . Of these, 21,802 individuals returned completed questionnaires, generating a 63.3% response rate (RR). Respondent and nonrespondent characteristics were compared (Appendix Table A1 , online only). Individuals age less than 55 years (RR, 56.0%) or more than 85 years (RR, 49.0%), those from a nonwhite ethnic group (Asian RR, 42.0%; black RR, 43.1%), and those living in the most socioeconomically deprived areas (RR, 52.1%) were less likely to participate.
Data Quality
Missing data levels were low, at approximately 5% for most fields. For example, 5.4% of respondents did not answer the question on LTCs and 5.7% did not report their disease status (Appendix Table A2 , online only).
Characteristics of the Population
Across the sample, 62.3% of patients were diagnosed with colon cancers, 30.8% with rectal cancers, and 6.9% with rectosigmoid tumors. Rectal cancer respondents were younger, with a higher proportion being male (Table 1) . Other LTCs were common, with only one fifth (21.3%) of patients reporting no LTCs and 43.5% of patients reporting two or more. Overall, 6.7% of respondents were diagnosed with metastatic disease (Dukes' stage D), and three quarters (76.3%) of respondents reported being in remission. Of the respondents, 92.3% reported having surgery, 46.8% chemotherapy, and 19.7% radiotherapy. The figures for surgery and chemotherapy were similar across the three sites, whereas, as would be anticipated as a result of best practice, a higher proportion of the group with rectal cancer (54.3%) received radiotherapy (compared with 3.5% of respondents with colon cancer and 16.9% of respondents with rectosigmoid cancer). A stoma was present in 9.8% of respondents with colon cancer, 20.6% of respondents with rectosigmoid cancer, and 42.4% of respondents with rectal cancer. In total, 34.9% of patients reported having had a stoma reversed.
Generic PROMs
A third of all respondents (34.5%) reported perfect health (no problems on any of the EQ-5D domains). Respondents with rectal cancer were more likely to report problems (70.9%) than respondents with rectosigmoid or colon cancer (63.8% and 63%, respectively; P Ͻ .001; Table 2 ). Problems were most commonly reported with pain/discomfort (43.1%) and usual activities (42.9%). Respondents with rectal cancer were significantly more likely to report problems in all domains except the mobility domain. Table 3 lists the number of problems reported in relation to the different population characteristics. Reporting of Ն one problem was highest in those with active (90.8%) or recurrent (87.9%) disease, those with Ն three other LTCs (83.3%), those with a stoma present (80.3%), and those older than age 85 (79.4%). Overall, 9.6% of respondents indicated having some level of problem in all five domains, and this was highest in those with active disease (24.1%) and those with Ն three other LTCs (20.6%).
These effects persisted in multivariable analysis where Ն three LTCs (odds ratio [OR], 5.56; 95% CI, 5.00 to 6.18 compared with no LTCs), active disease (OR, 5.38; 95% CI, 4.30 to 6.73 compared with remission), and presence of a stoma (OR, 2.34; 95% CI, 2.12 to 2.59 compared with no stoma) were the strongest predictors of less than perfect health (problems on Ն one domain). In addition, being female, living in a more deprived area, and receiving treatment including radiotherapy and/or chemotherapy were predictive of less than perfect health. Individuals age 55 to 84 years were less likely to report problems (compared with those Ͻ 55 years old), whereas the oldest age group (Ն 85 years) reported similar outcomes to those age less than 55 years.
Survivors of CRC were more likely to report problems on Ն one domain than the general population (68.8% v 59.9% in the matched HSE 2011 20 data; P Ͻ .001). This was mainly seen in those younger than age 55 years, where 73.1% of survivors of CRC and 49.6% of the general population reported problems (P Ͻ .001; Fig 2) . Outcomes were similar in the older age groups. Survivors of CRC with no other LTCs reported worse health than the general population with no LTCs (58.7% v 40.2% reporting problems, respectively; P Ͻ .001). 
Cancer-Specific PROMs
Bowel control. Analysis of questions relating to bowel function was limited to those without a stoma present. Overall, 16.3% of respondents (without a stoma) reported having no control of their bowels (Table 4) . This was higher in the group with colon cancer (17.5% compared with 15.4% and 13.0% of patients with rectosigmoid and rectal cancer, respectively; P Ͻ .001); however, the proportion answering "a little" or "somewhat" (moderate problems) was higher in the rectal cancer group (26.0% v 13.5% and 18.3% in the colon and rectosigmoid groups, respectively; P Ͻ .001). Patients with a reversed stoma were less likely to report having no bowel control than those who never had a stoma (12.0% v 16.6%, respectively; P Ͻ .001) but were more likely to report moderate problems ("a little" or "somewhat") than those with no stoma (25.9% v 14.0%, respectively; P Ͻ .001). Overall, 6.7% of respondents reported having diarrhea "quite a bit" or "very much," and this was similar across the three tumor sites (P ϭ .353).
Urinary function. The proportion of respondents reporting problems with difficulty urinating or leaking urine was low; 3.8% and 4.6% of respondents answered "quite a bit" or "very much" to the questions regarding difficulty urinating and leaking urine, respectively (Table 4) . A higher proportion of respondents reported problems with urinating more frequently (12.7%). When considered together, 15.4% of respondents answered "quite a bit" or "very much" to any of the three urinary function questions. The figure was higher for the rectal cancer group than the colon and rectosigmoid groups (17.9%, 14.1%, and 15.1%, respectively; P Ͻ .001). By sex, the figures were 16.0% in males and 14.5% in females (P ϭ .004).
Body image and sexual matters. Overall, 10.1% of respondents reported difficulties with their appearance or body image (answered "quite a bit" or "very much"), and this percentage was higher in the rectal group (13.9% v 9.8% in the rectosigmoid group and 8.2% in the colon group;PϽ.001;Table4).Individualswithastoma(ofwhomthemajority had rectal cancer) reported more difficulties (20.9% v 6.6% and 10.1% in the no stoma and reversed stoma groups, respectively; P Ͻ .001).
Rectal cancer respondents were more likely to report difficulties with sexual matters (25.1% answered "quite a bit" or "very much" v 11.2% of colon and 16.1% of rectosigmoid cancer respondents; P Ͻ .001; Table 4 ). Of those with a stoma present, 27.2% reported sexual difficulties compared with 10.8% without a stoma (P Ͻ .001). After radiotherapy, 30.1% of respondents reported sexual difficulties compared with 12.4% who were not irradiated (P Ͻ .001). A high proportion of respondents (36.9%) selected "does not apply" as their answer to the sexual difficulties question.
DISCUSSION
To our knowledge, this is the first study to report the HRQL outcome of a large nonselected national population living with and beyond a diagnosis of CRC. The major finding that more than one third of individuals surviving 12 to 36 months from a diagnosis of CRC report being in perfect health (ie, no problems on EQ-5D) is reassuring. However, certain subgroups report more problems, notably those with one or more other LTCs, those with active or recurrent disease, those with a stoma, and those at the extremes of the age range (Ͻ 55 and Ͼ 85). The results confirm emergent findings from previous smaller studies [21] [22] [23] [24] and identify groups that may have ongoing health challenges requiring targeted support and services.
Poorer HRQL, relative to the general population, was most marked in the younger age group, with little difference seen in those older than age 65. This has been suggested previously by a singleinstitution study of 309 survivors in Germany. 21, 22 This age effect may be explained by the gap hypothesis of quality of life, 25 with younger populations expecting to live in relatively good health, while older patients may have lower expectations or already be living with other LTCs.
Just more than 16% of all survivors of CRC without a stoma reported having no control of their bowels, with a further 17% reporting moderate problems (little or some control). These problems were not confined to the rectal cancer group and were highly prevalent relative to the general population. In HSE 2011, 20 9% of those older than age 65 answered "yes" to the question, "Do you suffer from problems with controlling your bowels?" Reversal of a stoma appeared to result in fewer severe bowel problems but more moderate problems than those who had never had a stoma. This finding requires further investigation. Concerning sexual matters, 15.9% of respondents reported experiencing severe difficulties ("quite a bit" or "very much") with patients with rectal cancer reporting a higher percentage (25.1%). Obtaining reliable intelligence on this subject is complex. 26 In one trial, baseline and 2-year sexual function questions were answered by just 21% and 11% of women, respectively. 10 In the current study, although only 5.8% gave no response, more than one third of respondents answered "does not apply," and this response was higher in women than men (48.3% and 28.9%, respectively). The difficulties in capturing responses to questions on sexual function may explain the wide variation in results from previous studies; estimates of incidence of sexual dysfunction in survivors of CRC range from 23% to 69% in men and 19% to 62% in women. 27 Severe urinary problems were reported by 15.4% of respondents. This relatively low proportion is reassuring. Research in the United States has shown that older survivors of CRC report similar levels of urinary incontinence compared with those without cancer.
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This study highlights easily identifiable factors associated with poor reported health outcomes. This emerging intelligence must be used by national initiatives, such as the National Cancer Survivor 
Health-Related Quality of Life After Colorectal Cancer in England
www.jco.org
Initiative in England, 29 to generate risk-stratified pathways of aftercare. Coordination of care has been shown to be important in driving up the quality of supportive care in CRC. 4 Services must ensure this is provided to individuals at increased risk of morbidity. Similarly, cost-effective interventions for the alleviation of bowel morbidity after cancer have been identified. For example, a randomized trial found that structured algorithm-driven management of patients with GI symptoms after pelvic irradiation can give sustained clinical improvement in bowel function. 30 The magnitude of bowel control problems reported in this study supports the widespread implementation of such interventions.
The survey achieved a response rate of 63%. This is higher than similar, but smaller, studies of survivors of CRC in the United States (54% response) 31 and Canada (34% response) 32 and comparable to a recent study of US veterans with CRC (63% response). 4 Studies from the Netherlands have reported higher response rates (Ͼ 70%), although some screening for eligibility was undertaken (eg, excluding terminally ill patients).
23,33 Our response rate is reported according to guidelines 34 without exclusion or screening of eligible individuals. There were differences in the characteristics of those who did and did not respond, with the elderly, ethnic minorities, and those from more socioeconomically deprived areas being less likely to participate. Given the characteristics of the nonrespondents, it is likely that they would experience poorer outcomes and that the results presented here may underestimate the true impact of CRC.
The analysis of HRQL focused only on the reporting (or not) of problems on the EQ-5D domains. The distribution of the EQ-5D data makes any analysis complex. In addition, we would argue that the calculation of scores from patient responses using weights from the general population is flawed. To overcome this, a simple approach has been presented.
Items were selected from the FACT subscales as a result of previous cognitive testing. 4 The effect of omission of items on the psychometric properties is not known. However, single-item responses have been evaluated separately, and any effect is likely to be similar across all subsample groups (ie, colon, rectosigmoid, rectal cancer).
Finally, this study relies on self-reports that have not been verified through comparison with patient records or other sources.
Encouragingly, however, in a large study of patients with breast cancer, excellent concordance was found in regard to disease-and treatment-related information between the medical record and patient self-report. 35 This study demonstrates the success of a national patientreported outcomes survey. Although one third of respondents reported no problems on assessment of HRQL, the results identify subgroups that are more likely to report problems. This approach has the potential to support system-wide improvement through the identification of particular challenges faced by individuals after treatment for CRC and those at greatest risk of poor outcomes.
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